| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |